JPH0672106B2 - Laxative composition - Google Patents
Laxative compositionInfo
- Publication number
- JPH0672106B2 JPH0672106B2 JP9917287A JP9917287A JPH0672106B2 JP H0672106 B2 JPH0672106 B2 JP H0672106B2 JP 9917287 A JP9917287 A JP 9917287A JP 9917287 A JP9917287 A JP 9917287A JP H0672106 B2 JPH0672106 B2 JP H0672106B2
- Authority
- JP
- Japan
- Prior art keywords
- oil
- seed
- water
- swelling
- fat
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Landscapes
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Description
【発明の詳細な説明】 〔産業上の利用分野〕 本発明は緩下剤組成物に関し、更に詳細には、水分散性
がよく、服用容易な剤形で投与することのできる緩下剤
組成物に関する。TECHNICAL FIELD The present invention relates to a laxative composition, and more particularly to a laxative composition which has good water dispersibility and can be administered in a dosage form easy to take.
プランタゴオバタ種皮、カルボキシメチルセルロース、
アルギン酸ナトリウム等の膨潤性下剤類は、大便の嵩を
増し、大便の含水量を高めることにより排便を容易にし
便秘を緩和するものである。Plantago ovata seed coat, carboxymethyl cellulose,
Swelling laxatives such as sodium alginate increase the bulk of stool and increase the water content of stool to facilitate defecation and relieve constipation.
しかしながら、これらの膨潤性下剤類は水と接触すると
その表面にゲル状の水和物を形成してしまい、いわゆる
ダマとなるため水に対する分散性が悪く、その結果消化
管内における均一な膨潤が得られないという欠点があ
る。それにもかかわらず、これは通常、服用前に水又は
飲料に分散させてから投与する方法によつて使用されて
いた。However, these swelling laxatives form a gel-like hydrate on the surface when they come into contact with water, so that they become so-called lumps and have poor dispersibility in water, resulting in uniform swelling in the digestive tract. There is a drawback that you cannot do it. Nevertheless, it has usually been used by the method of administration in water or a drink before administration.
しかし、この方法においても水等への分散が容易でない
と共に、膨潤によつて嵩が大きくなるため服用が困難で
あるという欠点があつた。However, this method also has drawbacks that it is not easy to disperse in water and the like, and the swelling increases the bulk, which makes it difficult to take.
斯かる欠点を克服するための種々の研究がなされてお
り、例えば、膨潤性下剤類を多量の糖と混合する方法、
その粒子をポリエチレングリコール、ポリビニルピロリ
ドンでコーテイングする方法(特開昭59-500417号)に
よつて水分散性を向上させることが報告されている。し
かしながら、これらの方法によつてもその効果は充分で
なく、依然として服用前に水に分散して投与することを
免れなかつた。Various studies have been made to overcome such drawbacks, for example, a method of mixing swelling laxatives with a large amount of sugar,
It has been reported that a method of coating the particles with polyethylene glycol or polyvinylpyrrolidone (JP-A-59-500417) improves water dispersibility. However, the effect is not sufficient even by these methods, and it is still unavoidable to disperse and administer in water before taking.
斯かる実状において、本発明者は上記問題点を解決せん
と鋭意研究を行つた結果、膨潤性下剤類を油脂中に分散
させれば、水に接触させた場合ダマになりにくく、この
ため水に対する分散性が向上し、消化管内で均一に膨潤
して優れた下剤効果を奏するので、予め水で膨潤させた
後に服用させる必要がなく、その結果、錠剤、丸剤、カ
プセル剤、顆粒剤等の服用容易な剤形として投与できる
ことを見出し、本発明を完成した。In such an actual situation, the present inventor has conducted diligent research to solve the above problems, and as a result of dispersing swelling laxatives in fats and oils, it is less likely to become lumps when brought into contact with water, and therefore water. Dispersibility in the digestive tract is improved and an excellent laxative effect is exerted, so there is no need to take it after swelling with water beforehand, and as a result, tablets, pills, capsules, granules, etc. The present invention has been completed by finding that it can be administered as a dosage form which is easy to take.
すなわち、本発明は、膨潤性下剤及び油脂を含有する緩
下剤組成物を提供するものである。That is, the present invention provides a laxative composition containing a swelling laxative and an oil or fat.
本発明において使用される膨潤性下剤類としては特に制
限されないが、例えばプランタゴオバタ種皮(イスパグ
ラ種皮)、グルコマンナン、アルギン酸ナトリウム、寒
天、カラギーナン、グアーガム、ローカストビーンガ
ム、タマリンドガム、アラビアガム、カラヤガム、トラ
ガントガム、ペクチン等の各種食物繊維類や天然水溶性
高分子類;カルボキシメチルセルロース、カルボキシメ
チルセルロースナトリウム、カルボキシメチルセルロー
スカルシウム、カルボキシエチルセルロース、ポリアク
リル酸ソーダ、ポリビニルアルコール、ポリビニルピロ
リドン、ヒドロキシエチルセルロース、ヒドロキシプロ
ピルセルロース、メチルセルロース等の合成水溶性高分
子物質が挙げられる。これらの中でもプランタゴオバタ
種皮、アルギン酸ナトリウム、カルボキシメチルセルロ
ースナトリウム、カルボキシメチルセルロース、就中特
にプランタゴオバタ種皮が好ましい。これらは単独で
も、また2種以上を組み合わせても使用できる。また、
これら膨潤性下剤類は粉末(好ましくは粒径0.1mm以
下)として用いるのが好ましい。The swelling laxatives used in the present invention is not particularly limited, for example, plantago ovata seed coat (ispagra seed coat), glucomannan, sodium alginate, agar, carrageenan, guar gum, locust bean gum, tamarind gum, gum arabic, karaya gum, Various dietary fibers such as tragacanth gum and pectin and natural water-soluble polymers; carboxymethyl cellulose, sodium carboxymethyl cellulose, carboxymethyl cellulose calcium, carboxyethyl cellulose, sodium polyacrylate, polyvinyl alcohol, polyvinylpyrrolidone, hydroxyethyl cellulose, hydroxypropyl cellulose, methyl cellulose Synthetic water-soluble polymer substances such as Of these, plantago ovata seed coat, sodium alginate, sodium carboxymethyl cellulose and carboxymethyl cellulose are preferred, and plant tag ovata seed coat is particularly preferred. These may be used alone or in combination of two or more. Also,
These swelling laxatives are preferably used as a powder (preferably having a particle size of 0.1 mm or less).
また、本発明に使用される油脂としては、融点が37℃以
下である食用可能な油脂であればいずれも使用可能であ
るが、例えばアサ実油、アマニ油、イサノ油、ウルシ核
油、エゴマ油、オイチシカ油、カヤ油、クルミ油、ケシ
油、サクランボ種皮油、ザクロ種子油、サフラワー油、
シナギリ油、大豆油、タバコ種子油、トウハゼ核油、日
本キリ油、ゴム種子油、ヒマワリ種子油、ブドウ核油、
ホウセンカ種子油、ミツバ種子油、ルンバナツト油、ア
ンズ核油、オレンジ種子油、カボチヤ種皮油、カラシナ
種子油、キウリ種子油、クロカラシ油、ゴマ油、コムギ
胚芽油、西洋スモモ核油、ダイコン種子油、トウモロコ
シ油、トマト種子油、ナタネ油、ニンジン種子油、ヌカ
油、ペカン油、ヘントウ油、ホウレンソウ種子油、綿実
油、モモ核油、レモン種子油、アサガオ種子油、ウイキ
ヨウ油、オリブ油、オリブ核油、カシユウ実油、カボツ
ク油、キヤベツ種子油、コーヒー種子油、サザンカ油、
シロモジ種子油、茶種子油、ツヅ油、ツバキ油、トウハ
ク油、バツカク油、ヒマシ油、ムクロジ種子油、落花生
油、イリベ油、ウルシロウ、カカオ脂、ガルシニア脂、
クス実脂、クスム脂、ゲツケイジユ実油、コーフン核
油、ゴルリ脂、シア脂、大風子油、ツカン油、ツカン核
油、デイカ脂、トウバゼ脂、トンカ豆脂、ニクズク脂、
ニツケイ脂、バクリー油、ババス核油、パーム油、パー
ム核油、ヒドノカルプス油、ボルネオ脂、マラバル脂、
ムルムル脂、モクロウ、ヤシ油等の植物性油脂;牛脂、
豚脂、乳脂、魚油等の動物性油脂;ハードフアツトに代
表される坐剤用基剤(例えば花王(株)製イソカカ
オ);スクワラン、スクワレン等の炭化水素、各種合成
または精製脂肪酸エステル類、モノグリセリド、ジグリ
セリド、トリグリセリド等が挙げられる。これらの中で
特に坐剤基剤、脂肪酸エステル類及び大豆油、ナタネ油
等の日本薬局方収載の油脂が好ましく、特に融点30〜37
℃の坐剤基剤(油脂類)が好適である。これらは単独で
も、また2種以上を組み合わせても使用できる。Further, as the fat and oil used in the present invention, any edible fat and oil having a melting point of 37 ° C. or lower can be used, and for example, hemp seed oil, linseed oil, isano oil, sumac kernel oil, and sesame seeds. Oil, ouch deer oil, kaya oil, walnut oil, poppy oil, cherry seed coat oil, pomegranate seed oil, safflower oil,
Cinnamon oil, soybean oil, tobacco seed oil, tallow gopher kernel oil, Japanese millet oil, rubber seed oil, sunflower seed oil, grape kernel oil,
Lozenge seed oil, honeysuckle seed oil, rumba nut oil, apricot kernel oil, orange seed oil, cabbage seed oil, mustard seed oil, cucumber seed oil, black mustard oil, sesame oil, wheat germ oil, western plum kernel oil, radish seed oil, corn Oil, tomato seed oil, rapeseed oil, carrot seed oil, bran oil, pecan oil, enthusiast oil, spinach seed oil, cottonseed oil, peach kernel oil, lemon seed oil, morning glory seed oil, quiche oil, olive oil, olive kernel oil, Cashew seed oil, cabbage oil, cabbage seed oil, coffee seed oil, southern oil,
Shiromoji seed oil, tea seed oil, camellia oil, camellia oil, apricot oil, jackpot oil, castor oil, sucrose seed oil, peanut oil, iribe oil, urshiro, cocoa butter, garcinia butter,
Kusu nut fat, Kusumu oil, radix ginseng oil, Kofun kernel oil, Gorri oil, Shea butter, Taiko oil, Tsukan oil, Tsukan kernel oil, Deika butter, Tobaze butter, Tonka bean butter, nutmeg fat,
Citrus butter oil, bakery oil, babassu kernel oil, palm oil, palm kernel oil, hydrocarpus oil, borneo butter, malabar butter,
Vegetable fats and oils such as succulent fat, mokuro and coconut oil; beef tallow,
Animal fats and oils such as lard, milk fat and fish oil; suppository bases represented by hard fat (for example, Isacao manufactured by Kao Corporation); hydrocarbons such as squalane and squalene, various synthetic or purified fatty acid esters, monoglycerides, Diglyceride, triglyceride and the like can be mentioned. Of these, suppository bases, fatty acid esters and soybean oil, oils and fats listed in the Japanese Pharmacopoeia such as rapeseed oil are particularly preferable, and particularly have a melting point of 30 to 37.
Suppository bases (oils and fats) at ℃ are suitable. These may be used alone or in combination of two or more.
本発明の緩下剤組成物は、膨潤性下剤類を1/10〜10重量
倍、好ましくは1/4〜5重量倍の油脂と混合し、これを
錠剤、丸剤、顆粒剤、カプセル剤等に製剤化することに
より得られる。混合は、液上油または固形脂を融解して
液状にしたものに膨潤性下剤類を分散させる方法、ある
いは液上油を粉体に吸着させたものまたは固形脂を粉末
とし、これに膨潤性下剤類を混合する方法によつて行な
われる。In the laxative composition of the present invention, swelling laxatives are mixed with 1/10 to 10 times by weight, preferably 1/4 to 5 times by weight of fats and oils to prepare tablets, pills, granules, capsules and the like. It is obtained by formulating. Mixing is a method of dispersing swelling laxatives in a liquid by melting liquid oil or solid fat, or by making liquid oil adsorbed on powder or solid fat into powder, and swelling It is carried out by a method of mixing purgatives.
本発明の緩下剤組成物には、上記成分の他に、一般に緩
下剤組成物に用いられる公知の各種成分、例えばビサコ
ジル、ダンスロン等の刺激性下剤、酸化マグネシウム等
の塩類下剤、ジオクチルソジウムスルホサクシネート等
の浸潤性下剤、瀉下補助緩和成分、健胃成分、粘度調整
剤、保存剤、安定化剤、矯味剤、賦香剤、コーテイング
剤等を必要に応じて配合することができる。In the laxative composition of the present invention, in addition to the above components, various known ingredients generally used in laxative compositions, for example, stimulant laxatives such as bisacodyl and danslon, salt laxatives such as magnesium oxide, dioctylsodium sulfosuccinate. Infiltrative laxatives such as the following, a cathartic auxiliary relaxation ingredient, a stomachic ingredient, a viscosity modifier, a preservative, a stabilizer, a flavoring agent, a flavoring agent, a coating agent and the like can be blended as necessary.
本発明の緩下剤組成物は、水に対する分散性に優れるた
め消化管内で均一に膨潤し、かつ服用しやすい剤形に製
剤することができるものである。Since the laxative composition of the present invention has excellent dispersibility in water, it can be formulated into a dosage form that swells uniformly in the digestive tract and is easy to take.
次に実施例を挙げて説明するが、本発明はこれらに限定
されるものではない。Next, examples will be described, but the present invention is not limited thereto.
実施例1 第1表に示す成分を用いて緩下剤組成物を調製し、それ
ぞれを局方カプセルO号に充填した。Example 1 A laxative composition was prepared by using the ingredients shown in Table 1, and each was filled in a pharmacopoeia capsule No. O.
上記カプセル剤をそれぞれ50ml三角フラスコ中、35℃、
50mlの蒸留水に投入し、直後に5mm径、15mm長の攪拌子
を用いて約700r.p.m.にて攪拌を開始し、水に対する分
散性を調べた。30分後、本発明品は均一に分散したが、
比較品は大きな塊のまま分散しなかつた。 Each of the above capsules in a 50 ml Erlenmeyer flask at 35 ° C,
The mixture was poured into 50 ml of distilled water, and immediately after that, stirring was started at about 700 rpm with a stirrer having a diameter of 5 mm and a length of 15 mm, and the dispersibility in water was examined. After 30 minutes, the product of the present invention was uniformly dispersed,
The comparative product did not disperse as a large lump.
実施例2 坐剤用基剤であるイソカカオMO-5(花王(株)製)を融
解し、第2表に示す比率でプランタゴオバタ種皮末を分
散させ、容量0.5cc宛の鋳型を用いて錠剤様に固化させ
る。Example 2 Isocacao MO-5 (manufactured by Kao Corporation), which is a suppository base, was melted, and plantago octopus seed coat powder was dispersed at the ratio shown in Table 2, and tablets were prepared using a template with a volume of 0.5 cc. To solidify.
No.1〜4について、プランタゴオバタ種皮1gに相当する
錠剤数を36℃、50mlの蒸留水に投入して攪拌し、5分後
に観察したところ、いずれも水中に均一に分散した。こ
れに対し、油脂を含まない対照(No.5)のプランタゴオ
バタ種皮末(1g)は水中に均一に分散せず、まま粉状態
となつた。 Regarding Nos. 1 to 4, the number of tablets corresponding to 1 g of plantago ovata seed coat was placed in 50 ml of distilled water at 36 ° C., stirred, and observed after 5 minutes. All were uniformly dispersed in water. On the other hand, the control (No. 5) plantago ovata seed coat powder (1 g), which did not contain fats and oils, did not disperse uniformly in water, and remained powdery.
Claims (1)
とする緩下剤組成物。1. A laxative composition comprising a swelling laxative and an oil and fat.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP9917287A JPH0672106B2 (en) | 1987-04-22 | 1987-04-22 | Laxative composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP9917287A JPH0672106B2 (en) | 1987-04-22 | 1987-04-22 | Laxative composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS63264534A JPS63264534A (en) | 1988-11-01 |
| JPH0672106B2 true JPH0672106B2 (en) | 1994-09-14 |
Family
ID=14240231
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP9917287A Expired - Lifetime JPH0672106B2 (en) | 1987-04-22 | 1987-04-22 | Laxative composition |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0672106B2 (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5126150A (en) * | 1990-10-01 | 1992-06-30 | The Procter & Gamble Company | Compositions containing psyllium |
| US5258181A (en) * | 1992-03-02 | 1993-11-02 | The Procter & Gamble Company | Compositions containing psyllium |
| WO1993018756A1 (en) * | 1992-03-20 | 1993-09-30 | The Procter & Gamble Company | Anion exchange resin compositions |
| JP3725539B2 (en) * | 1993-02-26 | 2005-12-14 | 大正製薬株式会社 | Bisacodyl dosage form |
| AU1266895A (en) * | 1993-12-20 | 1995-07-10 | Procter & Gamble Company, The | Process for making laxatives containing dioctyl sulfosuccinate |
| AUPN634595A0 (en) * | 1995-11-03 | 1995-11-30 | Borody, Thomas Julius | Improved method for colonic evacuation |
| DE19633968C2 (en) * | 1996-08-22 | 2003-04-10 | Ruth Kraemer-Klink | laxative |
| MX2010001629A (en) * | 2007-08-10 | 2010-08-09 | Alessandro Sannino | Polymer hydrogels and methods of preparation thereof. |
-
1987
- 1987-04-22 JP JP9917287A patent/JPH0672106B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JPS63264534A (en) | 1988-11-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3146168A (en) | Manufacture of pharmaceutical preparations containing cellulose crystallite aggregates | |
| DE69907799T2 (en) | Chewable pharmaceutical composition with gelatin matrix | |
| AU594148B2 (en) | Gelatin-encapsulated controlled-release composition | |
| US3138525A (en) | Castor wax-amprotropine-resin compositions | |
| AU2018251256B2 (en) | Pullulan capsules | |
| JPS61246120A (en) | Floating long life releasable therapeutical composition | |
| DE3132518A1 (en) | "ALKALINE, ANALGETIC CAPSULE" | |
| JP2664753B2 (en) | Mixed composition for the treatment of hypercholesterolemia | |
| JPH0672106B2 (en) | Laxative composition | |
| FR2460666A1 (en) | PROCESS FOR THE PREPARATION OF SOYBEAN POLYSACCHARIDES WITH EASY DISAGGREGATION PHARMACEUTICAL COMPOSITIONS | |
| EP0080673B1 (en) | Guar gum preparation forms for oral administration | |
| JPH10509982A (en) | Introduction of NSAIDs using powdered hydrocolloid rubber obtained from higher plants | |
| JP3418583B2 (en) | Propolis composition and method for producing the same | |
| DE69423643T2 (en) | Foaming gelatin capsule filling | |
| CN1042492C (en) | Preparing method for apovincamine acid ethyl ester | |
| JP3278427B2 (en) | Method for producing capsules | |
| US3131121A (en) | Highly acidic cation exchange resin containing amprotropine cations | |
| CN115300533A (en) | Pharmaceutical composition containing pollen derivative | |
| JP2002003388A (en) | Constipation relief composition | |
| DE60303449T2 (en) | IMPROVED FILLING COMPOSITIONS | |
| JPS6138170B2 (en) | ||
| JPH0692319B2 (en) | Internal suspension containing antidiarrheal agent | |
| CN100500138C (en) | Xiaoaiping preparation against cancers and its making method | |
| DE3790355C2 (en) | Prodn. of preparations of high gastric acid binding capacity | |
| JP3515954B2 (en) | Propolis processed food |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| EXPY | Cancellation because of completion of term | ||
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20070914 Year of fee payment: 13 |